Kind Pharmaceutical
PrivateLast Round
Series C
Nov 12, 2025
Total Funding Raised
$141.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kind Pharmaceutical is a biopharmaceutical company that develops innovative medicines for the treatment of hematological diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kind Pharmaceutical Comparables
Compare Kind Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sermonix Pharma | 86% | |
| Olema Oncology | 81% | |
| Eisai | 80% |
Kind Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 12, 2025 |
Kind Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Light Venture Capital | Series C, Series B |
| C&D Emerging Industry Equity Investment | Series C |
| Efung Capital | Series B, Series C |
| Decheng Capital | Series B, Series A |
| Taiping Fund Management Co., Ltd. | Series C |
| Gaorong Capital | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
$57M round led by C&D Emerging Industry Equity Investment and Taiping Fund Management.
Kind Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kind Pharmaceutical's valuation, stock price, and market status.
Is Kind Pharmaceutical a public or private company?
Kind Pharmaceutical is a private company.
What is the current stock price of Kind Pharmaceutical?
Kind Pharmaceutical is a private company, so its shares have no public market price. Caplight tracks Kind Pharmaceutical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kind Pharmaceutical worth (valuation)?
Valuation information for Kind Pharmaceutical is not publicly available.
Can I buy Kind Pharmaceutical stock?
Kind Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kind Pharmaceutical's last funding round?
Kind Pharmaceutical's most recent funding round was Series C on November 12, 2025.
Who are the main investors in Kind Pharmaceutical?
Key investors in Kind Pharmaceutical include Northern Light Venture Capital, C&D Emerging Industry Equity Investment, Decheng Capital, Taiping Fund Management Co., Ltd., Gaorong Capital.
Will Kind Pharmaceutical IPO soon?
No public IPO plans have been announced for Kind Pharmaceutical.
How can I track Kind Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades in Kind Pharmaceutical's shares on secondary markets.